Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PPP1CB divergent transcript (PPP1CB-DT) is a noncoding RNA (ncRNA) transcribed in the direction opposite to the nearby PPP1CB gene, which encodes a catalytic subunit of protein phosphatase 1. PPP1CB-DT is classified as a divergent lncRNA and has been found in transcriptomic modules enriched for genes involved in myofibril assembly and muscle contraction. Although its precise biological function is not defined, such divergent ncRNAs may affect the expression of adjacent protein-coding genes (like PPP1CB) either by cis-regulatory mechanisms or through effects on local chromatin structure[3][4].
Not applicable; no drugs are known to target PPP1CB-DT.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PPP1CB divergent transcript (PPP1CB-DT).